Insulet Corp. (PODD)
148.41
-0.25
(-0.17%)
USD |
NASDAQ |
Sep 01, 16:00
148.00
-0.41
(-0.28%)
After-Hours: 16:13
Insulet Research and Development Expense (Annual) : 301.10M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 301.10M |
| December 31, 2024 | 219.60M |
| December 31, 2023 | 205.00M |
| December 31, 2022 | 180.20M |
| December 31, 2021 | 160.10M |
| December 31, 2020 | 146.80M |
| December 31, 2019 | 129.70M |
| December 31, 2018 | 88.61M |
| December 31, 2017 | 74.45M |
| December 31, 2016 | 55.71M |
| December 31, 2015 | 43.21M |
| Date | Value |
|---|---|
| December 31, 2014 | 27.90M |
| December 31, 2013 | 21.76M |
| December 31, 2012 | 24.36M |
| December 31, 2011 | 21.86M |
| December 31, 2010 | 16.57M |
| December 31, 2009 | 13.23M |
| December 31, 2008 | 13.10M |
| December 31, 2007 | 10.39M |
| December 31, 2006 | 8.094M |
| December 31, 2005 | 10.76M |
| December 31, 2004 | 9.026M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| DexCom, Inc. | 594.90M |
| Boston Scientific Corp. | 2.052B |
| PROCEPT BioRobotics Corp. | 71.28M |
| Globus Medical, Inc. | 146.94M |